ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Tomasi To Resign As Roswell Park President; Committee To Study NIH Grant Review Issues

December 15, 1995

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Cancer Letter Takes Two Weeks Off

August 28, 1987